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Abstract 26 
MicroRNAs (miRNAs) are small non-coding RNAs with profound regulatory roles in 27 
many areas of biology, including cancer. MicroRNA 155 (miR-155), one of the 28 
extensively studied multifunctional miRNAs, is important in several human malignancies 29 
such as diffuse large B cell lymphoma and chronic lymphocytic leukemia. Moreover, 30 
miR-155 orthologs KSHV-miR-K12-11 and MDV-miR-M4, encoded by Kaposi’s 31 
sarcoma-associated herpesvirus (KSHV) and Marek’s disease virus (MDV) respectively, 32 
are also involved in oncogenesis. In MDV-induced T-cell lymphomas and 33 
lymphoblastoid cell lines derived from them, MDV-miR-M4 is highly expressed. Using 34 
excellent disease models of infection in natural avian hosts, we showed previously that 35 
MDV-miR-M4 is critical for the induction of T-cell lymphomas as mutant viruses with 36 
precise deletions were significantly compromised in their oncogenicity. However, these 37 
studies did not elucidate whether continued expression of MDV-miR-M4 is essential for 38 
maintaining the transformed phenotype of tumor cells. Here using an in situ 39 
CRISPR/Cas9 editing approach, we deleted MDV-miR-M4 from the MDV-induced 40 
lymphoma-derived lymphoblastoid cell line MDCC-HP8.  Precise deletion of MDV-miR-41 
M4 was confirmed by PCR, sequencing, quantitative RT-PCR and functional analysis. 42 
Continued proliferation of the MDV-miR-M4-deleted cell lines demonstrated that MDV-43 
miR-M4 expression is non-essential for maintaining the transformed phenotype, despite 44 
its initial critical role in the induction of lymphomas. Ability to examine the direct role of 45 
oncogenic miRNAs in situ in tumour cell lines is valuable in delineating distinct 46 
determinants and pathways associated with the induction or maintenance of 47 
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transformation in cancer cells and will also contribute significantly to gain further 48 
insights into the biology of oncogenic herpesviruses.   49 
50 
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Importance 51 
Marek’s disease virus (MDV) is an alphaherpesvirus associated with Marek’s disease, a 52 
highly contagious neoplastic disease of chickens. MD serves as an excellent model for 53 
studying virus-induced T-cell lymphomas in the natural chicken hosts. Among the limited 54 
set of genes associated with MD oncogenicity, MDV-miR-M4, a highly expressed viral 55 
ortholog of the oncogenic miR-155, has received extensive attention due to its direct role 56 
in the induction of lymphomas. Using a targeted CRISPR-Cas9-based gene editing 57 
approach in MDV-transformed lymphoblastoid cell lines, we show that MDV-miR-M4, 58 
despite its critical role in the induction of tumours, is not essential for maintaining the 59 
transformed phenotype and continuous proliferation.  As far as we know, this is the first 60 
study where precise editing of an oncogenic miRNA has been carried out in situ in MD 61 
lymphoma-derived cell lines to demonstrate that it is not essential in maintaining the 62 
transformed phenotype.   63 
  64 
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Introduction 65 
MicroRNAs (miRNAs) are ~22-nucleotide small RNA molecules that function as master 66 
regulators of gene expression in many species including plants, worms, flies, animals, as 67 
well as in a number of viruses. Most of the virus-encoded miRNAs are seen in DNA 68 
viruses, with members of the family Herpesviridae accounting for the vast majority 69 
demonstrating the significance of miRNA-mediated gene regulation in the biology of 70 
herpesvirus infection (1-3). Identification of miRNAs encoded by human oncogenic γ-71 
herpesviruses such as Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr 72 
virus (EBV) as well as avian oncogenic α-herpesvirus Marek’s disease virus (MDV) has 73 
highlighted the potential contribution of the virus-encoded miRNAs towards the 74 
oncogenicity of these viruses. Among the several roles of the herpesvirus-encoded 75 
miRNAs such as immune evasion, control of viral latency/lytic replication and oncogenic 76 
potential (4-6), the role of viral orthologs of host miR-155 encoded by KSHV and MDV 77 
in oncogenesis has been most extensively studied (5, 7). As a multifunctional miRNA 78 
expressed primarily in the hematopoietic and cells of the immune systems, miR-155 is 79 
highly conserved in most species including humans and chickens, and are associated with 80 
different lymphomas (8-11). In EBV-induced B-cell transformation as well as in a 81 
number of EBV-associated B-cell lymphomas including Hodgkin’s lymphoma, diffuse 82 
large B-cell lymphoma (DLBCL) and Burkitt’s lymphoma in humans, upregulation of 83 
miR-155 resulting in escalated cell proliferation and neoplastic transformation has been 84 
reported (12, 13). KSHV, a human gammaherpesvirus associated with 85 
lymphoproliferative disorders such as primary effusion lymphoma (PEL), multicentric 86 
Castleman disease (MCD) and B lymphomagenesis in AIDS patients, encodes 25 87 
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miRNAs. Among these miRNAs, KSHV-K12-11 that plays critical role in pathogenesis 88 
is a functional ortholog of hsa-miR-155 sharing identical seed sequences (14-16). MDV 89 
encodes MDV-miR-M4-5p (miR-M4), a functional ortholog with identical seed 90 
sequences with miR-155 and KSHV-K12-11 that has been shown to play a critical role in 91 
the induction of lymphomas (6).  92 
Marek’s disease (MD) is a lymphoproliferative disease of chickens characterized by 93 
rapid-onset lymphomas in multiple organs, and infiltration into peripheral nerves causing 94 
paralysis. MD serves as an excellent model for studying virus-induced T-cell lymphomas. 95 
Among the more than 100 genes encoded by the MDV (17, 18), the basic leucine zipper 96 
protein Meq (MDV EcoRI Q), which is expressed both in lytic and latent infections 97 
undisputedly, is the most important viral gene associated with MD oncogenicity (19, 20). 98 
Deleting the Meq gene or inhibition of its important interactions with host proteins such 99 
as c-Jun, c-Fos and C-terminal binding protein (CtBP) can affect the oncogenicity of the 100 
virus (21-23). Although the viral telomerase RNA (vTR) also has been shown to promote 101 
MDV-induced oncogenesis (24), the role of MDV-encoded miRNAs in oncogenesis has 102 
drawn extensive attention (25-27). MDV encodes 14 miRNA precursors producing 26 103 
mature miRNAs which are clustered into three separate genomic loci within the repeat 104 
regions of the viral genome. MDV-miR-M4, located in the cluster 1, was shown to be the 105 
viral ortholog of miR-155 (28). The oncogenic property of miR-155 together with the 106 
observation of high level of miR-M4 expression in tumor cells and the identification of 107 
several cancer pathway-related target genes suggested the important role of this miRNA 108 
in MDV-induced oncogenesis. Indeed, we and others have previously demonstrated the 109 
direct role of miR-M4 in the induction of tumours using recombinant MDV engineered to 110 
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have deletion- or seed region- mutations in miR-M4 using in vivo experiments in 111 
chickens (6, 29). Furthermore, we showed that the loss of oncogenic phenotype of miR-112 
M4-deletion mutant of MDV can be partially rescued by MDV expressing gga-miR-155 113 
demonstrating the similarities in the function of the two orthologs (6). While the role of 114 
miR-M4 in the induction of MD lymphomas has been clearly demonstrated in these 115 
studies, it remains unclear whether continued high level expression of miR-M4 is 116 
essential for maintaining the transformed phenotype of MDV-transformed tumour cells. 117 
As clonal populations of transformed tumor cells with latent MDV genome and limited 118 
gene expression (30-32), lymphoblastoid cell lines (LCL) derived from MD lymphomas 119 
have served as valuable resources to understand distinct aspects of virus-host interactions 120 
in transformed cells. However detailed investigations into the role of different viral and 121 
host determinants in these cells have been difficult due to the lack of tools for 122 
manipulation of viral/host genomes of these cells in situ. Following our recent success in 123 
efficient editing of the MDV genome in cell culture systems in vitro that supports lytic 124 
virus replication (33), we explored the use of a gene editing approach in MDCC-HP8 cell 125 
line that is latently infected with GA strain of MDV. Using MDCC-HP8 cells that stably 126 
expressed Cas9 and synthetic gRNAs with two-part guide RNA system, we examined the 127 
effect of deleting miR-M4 to gain insights into its functional role. Continued proliferation 128 
of the miR-M4 knock-out cell lines suggested that expression of miR-M4 gene is not 129 
essential for maintenance of the transformed state of the tumor cell line MDCC-HP8, 130 
despite its known critical role in the induction of MD lymphomas 131 
Results 132 
Knockout of MDV-miR-M4 in HP8 cells 133 
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Based on the success of efficient editing of the MDV genome during lytic replication in 134 
infected chicken embryo fibroblast (CEF) cultures in our previous studies (33), we 135 
attempted editing of the latent MDV genome in virus-transformed cell lines. Initial 136 
attempt with transfected gRNA-Cas9-expression plasmid showed low editing efficiency, 137 
thought to be largely due to the relatively low transfection efficiency of the hard-to-138 
transfect MDV-transformed cell lines (data not shown). New gene editing strategy 139 
involving the transfection of synthetic gRNAs with two-part guide RNA system into 140 
MDV-transformed cell line stably expressing Cas9 (HP8-Cas9) showed great success.  141 
For the targeted editing of the MDV-miR-M4 in the latent viral genome in this cell line, 142 
two gRNAs M4-gN and M4-gC were designed using CRISPR guide RNA designing 143 
software (http://crispr.mit.edu/). M4-gN targeted the upstream sequence of the mature 144 
miR-M4 sequence and M4-gC targeted the sequence spanning the mature miR-M4 145 
sequence and the loop region of the pre-miRNA hairpin structure resulting in the 146 
predicated cleavage site exactly lies at the end of the miR-M4 mature sequence (Fig. 1a 147 
& 1b). Successful miR-M4 deletion would release a 54-nt fragment following the 148 
successful cleavage of the sequence by the two gRNAs. Considering the presence of 149 
several MDV genomes integrated in multiple chromosomes of the chicken genome based 150 
on fluorescence in situ hybridization (FISH) analysis (unpublished data) and the location 151 
of miR-M4 in the terminal repeat region which doubles the copy number of miR-M4, two 152 
distinct bands are expected with PCR tests on the genomic DNA from cells harvested 48 153 
h after transfection using specific primers located at the flanking region of Cas9 targeting 154 
sites. The top band of around 205-bp represented the unedited sequence or edited target 155 
site/s with small indels if the two sites are not cleaved simultaneously. The bottom 156 
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smaller band of around 151-bp product corresponded to the edited region with 54bp 157 
deletion between the two Cas9 cleavage sites. Interestingly, only the bottom band was 158 
detected by PCR analysis indicating the highly efficient cleavage with the two gRNAs 159 
with the majority of the cells transfected and edited efficiently. Despite of observation of 160 
single band, single cell sorting was carried out to obtain pure population of miR-M4 161 
deleted cell. Although only bottom band was obtained by PCR before sorting in the 162 
mixed population, clones with top band were predominant after single cell cloning (Fig. 163 
1c). Sequence analysis of four bottom bands confirmed that it represented the direct end 164 
joining product of two predicted Cas9 target sites (Fig. 1a). Interestingly, the sequences 165 
of all these four clones were identical suggesting that further screening of several 166 
additional clones may be required to identify variations within the edited sequences. The 167 
successful knockout of miR-M4 sequence was further confirmed by qRT-PCR analysis, 168 
using uninfected CEF as a negative control. As expected, miR-M4 was absent from all 169 
four miR-M4-deleted HP8 clones and control CEF, compared to the high level expression 170 
detected in the parental HP8-Cas9 cells (Fig. 1d). These experiments demonstrated that 171 
miR-M4 has been deleted successfully with two-part guide RNA system in HP8 cell line 172 
stably expressing Cas9.  173 
miR-M4 is not essential in maintaining the transformed phenotype of MDV-174 
transformed cell line 175 
miR-M4 has been shown to be essential for the MDV in inducing tumors (6, 29). To 176 
explore the role of miR-M4 in maintaining the transformed state, we examined the effect 177 
of deletion of miR-M4 on the proliferation of HP8 cells. For this, we carried out kinetic 178 
monitoring of proliferation of the wild type HP8-Cas9 and the miR-M4 deleted clones 179 
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using IncuCyte S3 Live-Cell Imaging system. The cell proliferation data in real time from 180 
the images collected at 4 hours intervals showed that the miR-M4-deleted clones 181 
proliferated at a significantly higher rate within the first three days compared to parental 182 
HP8-Cas9 cells although different clones showed different levels of significance at 183 
various time points. These results suggested that expression of miR-M4 was not essential 184 
for the proliferation phenotype of these transformed cells.   185 
Pu.1 is up-regulated in HP8-ΔmiR-M4 cells 186 
Having shown that miR-M4 can be deleted from HP8 cell line and that it is not essential 187 
for the continued proliferation of these transformed cells, we wanted to examine the 188 
effect of miR-M4 deletion on the expression of its target proteins. For this, we chose to 189 
analyze the expression levels of Pu.1, one of the very well characterised and validated 190 
miR-M4 target (28). This was first assessed using luciferase reporter assay by 191 
transfection of the reporter construct containing the wild-type predicted miR-M4-192 
response element (MRE) or the mutant MRE region of the 3′ UTR of Pu.1 into the miR-193 
M4-deleted and the parental HP8-Cas9 cells. This assay showed that the relative Renilla 194 
luciferase levels of reporter constructs with wild-type MRE sequences were reduced by 195 
nearly 40 % compared with the mutant MRE construct in the parental HP8-Cas9 cells.  196 
Compared to this, such reduction of luciferase levels was absent in all of the miR-M4 197 
deleted clones (Fig. 3a) demonstrating the functional effect of miR-M4 deletion on the 198 
Pu.1 target. Next, we determined the miR-M4-mediated silencing by directly measuring 199 
the level of Pu.1 expression in one of the selected mutant clones C48, along with the 200 
parental cells. Immunoprecipitation-Western blot analysis showed that Pu.1 expression 201 
level was much higher in miR-M4-deleted cells compared with the parental cells (Fig. 202 
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3b). Results from the reporter assay and the direct expression analysis of the Pu.1 target 203 
have thus confirmed the deletion and functional consequences of miR-M4 in the mutant 204 
C48 clone.  205 
Effect of miR-M4 deletion on expression of other viral miRNAs and Meq protein  206 
Having demonstrated successful knockout of miR-M4 from MDV genome in HP8 cell 207 
line, we next analyzed the effect of miR-M4 deletion on expression of other MDV-208 
encoded miRNAs and the major viral oncoprotein Meq. The 14 MDV-encoded miRNA 209 
precursors are clustered into three separate genomic loci. Cluster 1 (Meq cluster) 210 
containing miR-M2, 3, 4, 5, 9 and 12 located upstream of Meq gene. The mid-cluster 211 
containing three miRNA precursors (miR-M11, 31 and 1) located downstream of Meq. 212 
The third cluster, referred to LAT-cluster, lies within the first intron of latency-associated 213 
transcript (LAT). To assess the potential effect of miR-M4 deletion on other miRNAs, we 214 
first amplified the cluster 1 miRNAs by PCR with the primers at the flanking region of 215 
the cluster. Sequence of the PCR product was determined to confirm the absence of any 216 
changes (data not shown) except for the edited region as shown in Figure 1a. Next we 217 
analysed the expression of each miRNA in cluster 1, miR-M31 from cluster 2, miR-M6 218 
and miR-M8 from cluster 3 using the RNA extracted from miR-M4-deleted clone 48 and 219 
the parental HP8-Cas9. The host miRNA gga-let-7a was also measured, with total RNA 220 
from uninfected CEF used as control. As shown in Figure 4a, all viral miRNAs were 221 
absent and only let-7a was detectable in the CEF sample. Except for the absence of miR-222 
M4 from miR-M4-deleted clone 48, both the viral and the host miRNAs were detected in 223 
HP8 before or after miR-M4 deletion. Quantitation of selected viral miRNAs by qRT-224 
PCR indicated that they are still expressed in the miR-M4-deleted clone 48, although 225 
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their expression levels showed variation compared to the parental HP8 cells (Fig. 4a). We 226 
also examined Meq expression in the miR-M4-deleted cells by western blot analysis. An 227 
ALV-transformed B-cell line HP45 and uninfected CEF which do not express Meq were 228 
used as negative controls. Results of the western blot analysis confirmed the expression 229 
of Meq in the miR-M4-deleted cells, demonstrating that miR-M4 was not required for 230 
Meq expression in these cells (Fig. 4b). 231 
v-rel relieves the inhibition of miR-155 expression in HP8-ΔmiR-M4 232 
We have previously shown that miR-155 is consistently downregulated in MDV-233 
transformed tumours and cell lines (34) and this downregulation can be rescued by 234 
expressing v-rel that also activate the expression levels of miR-M4 in these cells (35). 235 
We wanted to examine whether the downregulation of miR-155 can be rescued without 236 
the activation of miR-M4 by transduction of v-rel with RCAS(A)-v-rel-GFP virus in 237 
HP8-ΔmiR-M4 clone 48. The GFP marker allowed sorting of the RCAS-infected cells. 238 
Analysis of the sorted cells by Western blotting confirmed the expression of v-rel-GFP in 239 
RCAS(A)-v-rel-GFP-infected cells and GFP expression in RCAS(A)-GFP infected cells 240 
(Fig. 5a). Expression of v-rel increased the level of miR-155 expression by 241 
approximately 6026-fold in HP8-ΔmiR-M4 cells but only 25-fold in HP8-Cas8 cells (Fig. 242 
5b), demonstrating that deletion of miR-M4 increased miR-155 expression induced by v-243 
rel. 244 
Discussion 245 
Virus-host interactions in herpesviruses are characterized by long term survival as latent 246 
infections in different cell types. With total dependence on the host cell, several viruses 247 
have adopted strategies to modulate the host cellular environment, including the 248 
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modulation of miRNAs. A number of studies have demonstrated the role of miRNAs in 249 
replication, pathogenesis and oncogenesis of herpesviruses (3, 4, 7, 36-38). These 250 
included our own studies demonstrating the critical role of miR-M4 in the induction of 251 
lymphomas by MDV (6). While these observations have also been confirmed by other 252 
studies (29), the role of viral miRNAs in maintaining the transformed state, as well as in 253 
other functions such as the switch of latency/lytic replication in tumor cells have not been 254 
examined. Particularly, the role of miR-M4, the viral ortholog of oncogenic miR-155 255 
encoded by oncogenic MDV, in maintaining the transformed phenotype of the tumor cell 256 
line is unknown. MDV-transformed LCLs derived from MD lymphomas which contain 257 
multiple copies of MDV genome integrated in different chromosomes are valuable to 258 
study latency, transformation and reactivation in situ.  Having established the 259 
CRISPR/Cas9-based editing of the viral genome at relatively high efficiency in MDV-260 
transformed cell lines, we report here the precise knockout of miR-M4 from the MDV 261 
genome in the LCL HP8. Results from these studies show that miR-M4, despite its 262 
critical role in the induction of lymphomas by oncogenic MDV strains, is not required for 263 
the continued proliferation of MDV-transformed HP8 LCL. As far as we know, this is the 264 
first study that makes use of the CRISPR/Cas9-based gene editing technology in situ to 265 
demonstrate that a critical virus-encoded miRNA is not essential to maintain the 266 
transformed phenotype of a virus-induced cancer cell line.  267 
By transfection of two parts synthetic gRNA into HP8 cells stably expressing Cas9, we 268 
have shown here that miR-M4 can be deleted at a relatively high efficiency (Fig. 1c). 269 
Considering the presence of the multiple copies of the target loci in these cell lines, the 270 
high editing efficiency highlighted that efficient gRNA, rather than the copy numbers of 271 
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the target genes, is the key to achieve the desired editing even in the hard-to-transfect cell 272 
lines such as the MDV-transformed LCL. Although the editing efficiency based on the 273 
PCR test on the transfected cell lines appeared to be very high, sorting of the single cell 274 
populations did identify a number of unedited clones, further highlighting the importance 275 
of single cell sorting in gene editing pipelines. These findings are also consistent with our 276 
observation that the recovery rate of edited cells is probably much lower than that of the 277 
unedited cell populations, suggesting that single cell cloning is a required step to get the 278 
pure populations of the edited cells regardless of the efficiency of gene editing.  The 279 
successful knockout of miR-M4 demonstrated the value of this approach in identifying 280 
other molecular determinants associated with different phenotypes including latency/lytic 281 
switch in LCLs.  While the growth of the miR-M4-deleted cells confirmed that the 282 
expression of miR-M4 is not essential to maintain the transformation and proliferation of 283 
LCL, ΔmiR-M4 cell line that we have generated will also be a valuable research tool for 284 
addressing significant biological questions in the future on the functional role of this 285 
important miRNA homolog. For example, it will be interesting to know if the populations 286 
of shared target genes of MDV-miR-M4, miR-155 and KSHV-miR-K12-11 (5) are 287 
upregulated in the miR-M4-deleted cells and downregulated after v-rel transduction 288 
which activates miR-155 expression (Fig. 5b). Similarly, future studies on the global 289 
analysis of the changes in the transcriptome and proteomes of the edited cell populations, 290 
together with changes in the viral and host epigenomes will throw more insights into the 291 
fine tuning of the molecular regulatory network around these family of miRNAs in these 292 
virus-transformed cell lines. Finally, these cells also give the opportunity to investigate 293 
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the role of miR-M4 to induce lymphomas (transplantable tumors) in vivo in 294 
experimentally-infected target chicken hosts.  295 
Repair by non-homologous end joining (NHEJ) is usually accompanied by random 296 
nucleotide insertion/deletion at cleavage site. As a result, the edited sequence is most 297 
likely to be a mixed population. However, sequencing results have shown that virtually 298 
all of edited sequences are end joining product of the two predicted Cas9 cleavage sites. 299 
Although additional variations may be discovered when more clones are analyzed, the 300 
edited loci often contained only predominant mutant sequence as we have shown 301 
previously (33, 39). The reasons for the clonal nature of the appearance of the single 302 
population are not fully clear. Whether this is related to the stable expression of the Cas9 303 
in these cells or due to other factors require further investigation. 304 
The oncogene v-rel activates miR-155 expression by binding to NF-κB site in Bic 305 
promoter. We have shown previously that the downregulation of miR-155 in MDV-306 
transformed cell lines could be rescued by expressing v-rel in these cells (35). Using the 307 
same approach, we have shown here that the downregulation of miR-155 can also be 308 
rescued in the context of miR-M4 deleted HP8 by transduction of v-rel with RCAS(A)-v-309 
rel-GFP virus in HP8-ΔmiR-M4 clone C48. Interestingly, only 25-fold increase of miR-310 
155 level could be induced in the unedited HP8-Cas9 cells compared to 6,026-fold 311 
increase in the miR-M4 deleted clone C48, suggesting that the absence of miR-M4 312 
significantly enhances the ability of v-rel to induce miR-155 expression in MDV tumor 313 
cell lines.  As has been demonstrated previously, miR-M4 is highly expressed in MDV 314 
tumor cell lines compared to the miR-155, which is actively downregulated, although the 315 
precise mechanisms of the differential downregulation have not been identified. Based on 316 
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the findings from the present study, it appears that the downregulation of miR-155 may 317 
be directly linked to high level of miR-M4 expression as the activation of miR-155 by v-318 
rel is more robust in the miR-M4-deleted cells. However, further studies are required to 319 
delineate the associated mechanisms involved in such regulation.  320 
The precise editing of the miR-M4 locus to abolish the expression of the mature miR-M4 321 
in the MDV-induced T-lymphoma-derived cell line HP8, clearly demonstrated that the 322 
proliferative capacity of the transformed cell line is not dependent on continued high 323 
level expression of miR-M4. The continued proliferation of cells is unlikely to be due to 324 
the inability to express other viral miRNAs such as all other miRNAs in cluster 1 and 325 
selected miRNAs from both mid-cluster and LAT-cluster detected by miRNA qRT-PCR 326 
(Fig. 4a). MDV-miR-M4 is very important for the oncogenicity of MDV but other 327 
miRNAs in the cluster also contribute since the mutant virus expressing miR-M4 alone in 328 
cluster 1 remained non-oncogenic (6). Whether or not other miRNA contribute to the 329 
maintenance of transformed phenotype remains to be elucidated. The continued 330 
proliferation of cells is also not due to the lack of expression of adjacent viral gene such 331 
as Meq as we were able to demonstrate the expression of the protein by western blot 332 
analysis (Fig. 4b). The significantly increased proliferation capacity of miR-M4 knockout 333 
clones suggests that miR-M4 in these context may have proliferation suppressor function. 334 
Additional studies on the detailed analysis of the gene expression profiles on these clones 335 
will be required to gain further insights into the biology of miR-M4 in these cells. 336 
Although it is possible that LCLs may have acquired other mutations that may have made 337 
them no longer dependent on miR-M4 for proliferation, the failure on rescuing Meq 338 
deleted cell line after repeated attempts indicated this is unlikely the case. Whether or not 339 
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other genes or miRNAs are involved in maintaining the transformed phenotype of MD 340 
tumor cell lines remains to be investigated.  341 
Materials and Methods 342 
Cell Culture  343 
The MDV-transformed lymphoblastoid cell lines HP8 (40) from a GA strain-induced 344 
tumour were grown at 38.5°C in 5% CO2 in RPMI 1640 medium (Life technologies) 345 
containing 10% fetal bovine serum, 10% tryptose phosphate broth, 1% sodium pyruvate 346 
solution (Sigma) and 100 units/mL of penicillin and streptomycin (Life technologies). 347 
gRNAs  348 
Two-part guide RNA system containing crRNA:tracrRNA guide complex was used for 349 
editing. The sequences of gRNA miR-M4-gN and miR-M4-gC listed in Table 1 were 350 
used for synthetic crRNAs production by Integrated DNA Technologies (IDT, USA). The 351 
tracrRNA was purchased from IDT. The lyophilized crRNA and tracrRNA pellets were 352 
resuspended in Duplex buffer (IDT) at 200 μM concentration and stored in small aliquots 353 
at −80°C.  354 
Generation and characterization of HP8-ΔmiR-M4 cell line 355 
NEPA21 Electroporator was used for the transfection of HP8 cells that stably expressed 356 
Cas9 (HP8-Cas9) (41). For the deletion of miR-M4, 1x10
6
 of HP8-Cas9 cells were 357 
resuspended in 96μL Opti-MEM medium. Two crRNAs miR-M4-gN and miR-M4-gC 358 
were mixed with equal molar amounts of tracrRNA to a final duplex concentration of 100 359 
µM in 4 µL of duplex buffer and incubated at 95°C for 5 min. After the duplex was 360 
allowed to cool to room temperature, it was mixed with cell suspension and 361 
electroporated using the conditions of voltage 275V and pulse width 1.5ms of poring 362 
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pulse. At 48 h post electroporation, 1x10
5
 cells were harvested and analysed by PCR. The 363 
remaining cells were sorted into 96 wells for single cell isolation. After 7 days 364 
incubation, cells were collected and analyzed by PCR. The harvested cell for PCR 365 
analysis were lysed in 1× protein K based DNA isolation buffer (33)  at 65 °C for 30 min. 366 
1 µL of extracted DNA template was used for PCR with primers outside the targeted sites 367 
to identify the correct miR-M4 gene knock-out. The primer sequences of miR-M4-F and 368 
miR-M4-R used for PCR are listed in Table 1. 369 
RCAS virus infection 370 
Virus stocks were generated from DF-1 cells transfected with RCAS(A)-EGFP and 371 
RCAS(A)-v-rel-EGFP constructs approximately 5 days after transfection, when  100% 372 
cells were EGFP-positive. For v-rel transduction in HP8-Cas9 and HP8-ΔmiR-M4, 1 ml 373 
(~10
6
 TCID50) of RCAS(A)-EGFP or RCAS(A)-v-rel-EGFP virus stock was used to 374 
infect 1x10
6
 of HP8-ΔmiR-M4 cells and HP8-Cas9 cells. EGFP expressing RCAS(A)-v-375 
rel-EGFP and RCAS(A)- EGFP infected HP8-ΔmiR-M4 and HP8-Cas9 cells were sorted 376 
into 6 well plates. After 7 days incubation, cells were collected and examined for v-rel, 377 
EGFP expression by western blot and miR-155 expression by qRT-PCR. 378 
Sorting 379 
For single cell cloning, cells were washed twice with PBS containing 5% FBS and 380 
centrifuged at 450g for 5 min at room temperature. The cell pellets were resuspended in 381 
cold PBS/5%FBS and sorted into 96 well plate U bottom (Corning) with growth medium 382 
by FACS using FACSAria II (BD bioscience). 383 
qRT-PCR analysis of miRNA expression 384 
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The expression level of miRNAs were analyzed using the TaqMan MicroRNA Assay 385 
System (Life Technologies) using 10 ng total RNA as a template for reverse transcription. 386 
Each reverse transcription reaction was tested by PCR in triplicate and performed twice 387 
independently. For relative quantification of miRNA-M4 in HP8-ΔmiR-M4 (Fig. 1d) and 388 
miR-155 in v-rel transduced cells (Fig. 5b), all values were normalized to the expression 389 
of the endogenous let-7a, and levels were calculated as fold-expression change relative to 390 
those from HP8-Cas9 cells (miR-155) and CEF (miR-M4). For relative quantification of 391 
viral miRNAs and host gga-let-7a in HP8-ΔmiR-M4 clone 48 and controls HP8-Cas9 and 392 
CEF (Fig.4a), all values were normalized to the expression of the endogenous GAPDH 393 
gene, and levels were calculated as fold-expression change relative to those from CEF. 394 
Dual luciferase reporter assay 395 
Previously constructed reporter construct for the validated miR-M4 and miR-155 target 396 
Pu.1 in psiCHECK vector was used to measure the miR-M4 activity in HP8 (28). The 397 
reporter constructs contain a 110-bp fragment of the chicken Pu.1 3′ untranslated region 398 
(UTR) sequence with MRE (Pu.1-3′UTR-wt) or MRE mutant sequence (Pu.1-3′UTR-mu) 399 
inserted downstream of Renilla luciferase in the psiCHECK-2 vector (Promega) (28). 400 
HP8-ΔmiR-M4 cells and HP8-Cas9 cells (5x105) were transfected with 4ug of either 401 
Pu.1-3′UTR-wt or Pu.1-3′UTR-mu using NEPA21 electroporator as described. The 402 
luciferase expression was assayed 48 h later using the Dual-Glo Luciferase Assay System 403 
(Promega) following the manufacturer’s instructions. The relative expression of Renilla 404 
luciferase was determined with the normalized levels of firefly luciferase. For each 405 
sample, values from four replicates representative of at least two independent 406 
experiments were used in the analysis. 407 
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Western blotting analysis 408 
Approximately 1x10
6
 HP8-ΔmiR-M4 cells and the control cells were collected and boiled 409 
with TruPAGE
TM
 LDS sample buffer (Sigma) for 10 min. The samples were separated on 410 
a 4-12% TruPAGE
TM
 Precast Gel, and the resolved proteins were transferred onto PVDF 411 
membranes. Expression of Meq, Pu.1, v-rel and GFP was detected using anti-Meq 412 
monoclonal antibody (Mab) FD7 (21), rabbit anti-SPIB polyclonal antibody (Aviva 413 
Systems Biology), anti-v-rel Mab HY87 (35) and GFP Polyclonal Antibody (SICGEN) 414 
respectively. α-tubulin (Sigma Aldrich) was used as loading control in all cases. After 415 
probing with primary antibodies, the blots were incubated with secondary antibody 416 
IRDye®680RD goat anti-mouse IgG (LI-COR) (for Meq, v-rel and α-tubulin detection), 417 
IRDye®800CW Donkey anti-rabbit IgG (LI-COR) (for Pu.1 detection),  IRDye®800CW 418 
Donkey anti-goat IgG (LI-COR) (for GFP detection) and visualized using Odyssey Clx 419 
(LI-COR). For GFP detection, the PVDF membrane used for v-rel detection was stripped 420 
and re-probed with GFP antibody following the same procedure.  421 
Analysis of HP8-Cas9-ΔmiR-M4 cell growth 422 
The growth of HP8-Cas9-ΔmiR-M4 clones along with non-edited HP8-Cas9 was 423 
monitored by IncuCyte S3 live cell imaging (Essen Bioscience Ltd, Hertfordshire, UK). 424 
Briefly, 8000 cells were seeded in a 96-well plate (Corning) and images were captured 425 
every 4h for 132h from four separate regions per well using a 10x objective.  By 426 
recording the phase object confluence, the growth of HP8-Cas9-ΔmiR-M4 clones were 427 
compared with parental HP8-Cas9. IncuCyte data was analysed by two-way ANOVA 428 
with Tukey’s multiple comparisons using GraphPad Prism version 7.01 (GraphPad 429 
Software, Inc., San Diego, CA). The results were shown as mean ± standard error (SE) 430 
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from four replicates each with 4 separate regions per well representative of three 431 
independent experiments. P values of < 0.05 were considered to be significant.  432 
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Figure legends 561 
Figure 1. Deletion of the miR-M4 by CRISPR/Cas9 editing in HP8 cells. (a) The 562 
nucleic acid sequences of the truncated/edited PCR products showing the successful 563 
deletion of miR-M4 on selected clones. Target sequence is underlined, PAM sequence is 564 
in light blue and the cleavage site is indicated by an arrow. (b) The predicated stem loop 565 
structure of the pre-miR-M4 with the predicated cleavage site indicated by an arrow. The 566 
sequence of the mature miRNA sequences are shown in red. (c) PCR amplification of the 567 
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edited region using primers NF and CR on the cell lysates of transfected cells at 2 days 568 
post transfection and on isolated single cell clones C7-C11. (d) Relative expression of 569 
miR-M4, measured by qRT-PCR in RNA extracted from miR-M4 deleted clones C7, 570 
C37, C40, and C48 along with the un-edited HP8-Cas9 and CEF. The level of miR-M4 in 571 
HP8-Cas9 was set as 1 for calibration.  572 
Figure 2. Proliferation of the HP8-Cas9 and the miR-M4 deleted clones monitored 573 
in real time using IncuCyte S3 live imaging system. Cell phase object confluence of 574 
each cell population was determined every 4h for 132h from 4 separate regions per well 575 
and 4 wells per sample in 96-well plate by IncuCyte and compared with HP8-Cas9 576 
control. Growth curves are shown as mean ± standard error (SE) representative of three 577 
independent experiments. Asterisk (*) indicates statistically significant differences 578 
between miR-M4 deleted clones and parental HP8-Cas9 cells at different times. *, 579 
p<0.05; **, p<0.01; ***, p<0.001; ****, p <0.0001. Asterisks were placed above the 580 
time points (single time points) or underneath the growth curves for those time points 581 
with the same results during the indicated period of time. 582 
Figure 3. Successful deletion of miR-M4 measured by functional studies. (a) Firefly 583 
and Renilla luciferase activities were measured consecutively with the dual luciferase 584 
reporter system (Promega) following transfection of reporter constructs containing the 585 
wild-type or the mutant MRE region of the 3′ UTR of miR-M4 target gene Pu.1 into the 586 
miR-M4 deleted cells and the parental HP8-Cas9. The relative expression of Renilla 587 
luciferase was determined with the normalized levels of firefly luciferase. For each 588 
sample, values from four replicates representative of at least two independent 589 
experiments were used in the analysis. The value from the psiCHECK-2-mutant was set 590 
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as 1. Error bars are derived from four replicates. (b) IP-western blot analysis of Pu.1 in 591 
miR-M4 deleted HP8 clone C48 and HP8-Cas9. Matched inputs were assayed for α-592 
tubulin as loading control. Relative signal intensities of the Pu.1 Western blot band were 593 
quantified using ImageQuant and normalized against the corresponding signal from the 594 
tubulin band. The signal from HP8-Cas9 cells was set as 1. 595 
Figure 4. MDV miRNAs and Meq protein expression in miR-M4 deleted cells. (a) 596 
Relative expression of each indicated viral miRNAs and host miRNA let-7a is measured 597 
by qRT-PCR with RNA extracted from miR-M4 deleted clone C48 along with the un-598 
edited HP8-Cas9 and CEF. All values were normalized to the expression of the 599 
endogenous GAPDH gene, and levels were calculated as fold-expression change relative 600 
to those from CEF. The level of each miRNA in HP8-Cs9 was set as 1. (b) Detection of 601 
Meq expression by western blotting with anti-Meq monoclonal antibody FD7 in HP8-602 
Cas9 and HP8-Cas9-ΔmiR-M4 clones. ALV transformed B-cell line HP45 and un-603 
infected CEF were included as negative controls. For the loading control, the same blot 604 
was stripped and reprobed with anti-α-tubulin antibody. 605 
Figure 5. Upregulation of miR-155 in miR-M4 deleted HP8 by v-rel. (a) Detection of 606 
v-rel expression with anti-v-rel monoclonal antibody HY87 and GFP expression with 607 
anti-GFP antibody by western blotting in HP8-ΔmiR-M4 clone C48 and HP8-Cas9 608 
infected with RCAS(A)-GFP or RCAS(A)-v-rel-GFP respectively.  For the loading 609 
control, the same blot was stripped and reprobed with anti-α-tubulin antibody. (b) 610 
Relative level of miR-155 expression was detected by qRT-PCR in HP8-ΔmiR-M4 clone 611 
C48 and HP8-Cas9 infected with RCAS(A)-GFP or RCAS(A)-v-rel-GFP respectively.   612 
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Table 1.  List of primer sequences  
 
Primer  Sequence (5’-3’)                                
 
miR-M4-gN  CGTGTTCCACGTGACGGCTC   
miR-M4-gC      CTGTATCGGAACCCTTCGTT   
   
miR-M4-F  TGAGGGGAGCGATCGACTC   
miR-M4-R  GATTCAATATTACATCACTTCAACGG    
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